Tibet Cheezheng Tibetan Medicine Statistics

Total Valuation

Tibet Cheezheng Tibetan Medicine has a market cap or net worth of CNY 12.14 billion. The enterprise value is 10.69 billion.

Market Cap	12.14B
Enterprise Value	10.69B

Important Dates

The last earnings date was Friday, October 25, 2024.

Earnings Date	Oct 25, 2024
Ex-Dividend Date	Jul 4, 2024

Share Statistics

Tibet Cheezheng Tibetan Medicine has 530.17 million shares outstanding. The number of shares has increased by 0.00% in one year.

Current Share Class	n/a
Shares Outstanding	530.17M
Shares Change (YoY)	+0.00%
Shares Change (QoQ)	+0.01%
Owned by Insiders (%)	0.30%
Owned by Institutions (%)	0.80%
Float	65.65M

Valuation Ratios

The trailing PE ratio is 20.43.

PE Ratio	20.43
Forward PE	n/a
PS Ratio	5.34
PB Ratio	3.15
P/TBV Ratio	n/a
P/FCF Ratio	25.52
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 17.88, with an EV/FCF ratio of 22.48.

EV / Earnings	18.00
EV / Sales	4.71
EV / EBITDA	17.88
EV / EBIT	21.26
EV / FCF	22.48

Financial Position

The company has a current ratio of 3.16, with a Debt / Equity ratio of 0.47.

Current Ratio	3.16
Quick Ratio	3.00
Debt / Equity	0.47
Debt / EBITDA	3.10
Debt / FCF	3.90
Interest Coverage	8.03

Financial Efficiency

Return on equity (ROE) is 15.90% and return on invested capital (ROIC) is 5.49%.

Return on Equity (ROE)	15.90%
Return on Assets (ROA)	4.86%
Return on Capital (ROIC)	5.49%
Revenue Per Employee	734,607
Profits Per Employee	192,193
Employee Count	3,091
Asset Turnover	0.35
Inventory Turnover	2.33

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +0.13% in the last 52 weeks. The beta is 0.64, so Tibet Cheezheng Tibetan Medicine's price volatility has been lower than the market average.

Beta (5Y)	0.64
52-Week Price Change	+0.13%
50-Day Moving Average	21.63
200-Day Moving Average	20.87
Relative Strength Index (RSI)	53.26
Average Volume (20 Days)	2,717,699

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Tibet Cheezheng Tibetan Medicine had revenue of CNY 2.27 billion and earned 594.07 million in profits. Earnings per share was 1.12.

Revenue	2.27B
Gross Profit	1.87B
Operating Income	503.00M
Pretax Income	672.72M
Net Income	594.07M
EBITDA	590.18M
EBIT	503.00M
Earnings Per Share (EPS)	1.12

Full Income Statement

Balance Sheet

The company has 3.35 billion in cash and 1.85 billion in debt, giving a net cash position of 1.50 billion or 2.83 per share.

Cash & Cash Equivalents	3.35B
Total Debt	1.85B
Net Cash	1.50B
Net Cash Per Share	2.83
Equity (Book Value)	3.91B
Book Value Per Share	7.28
Working Capital	2.94B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 807.59 million and capital expenditures -331.83 million, giving a free cash flow of 475.77 million.

Operating Cash Flow	807.59M
Capital Expenditures	-331.83M
Free Cash Flow	475.77M
FCF Per Share	0.90

Full Cash Flow Statement

Margins

Gross margin is 82.35%, with operating and profit margins of 22.15% and 26.16%.

Gross Margin	82.35%
Operating Margin	22.15%
Pretax Margin	29.63%
Profit Margin	26.16%
EBITDA Margin	25.99%
EBIT Margin	22.15%
FCF Margin	20.95%

Dividends & Yields

This stock pays an annual dividend of 0.48, which amounts to a dividend yield of 2.06%.

Dividend Per Share	0.48
Dividend Yield	2.06%
Dividend Growth (YoY)	23.08%
Years of Dividend Growth	n/a
Payout Ratio	47.83%
Buyback Yield	-0.00%
Shareholder Yield	2.06%
Earnings Yield	4.89%
FCF Yield	3.92%

Dividend Details

Stock Splits

The last stock split was on July 11, 2019. It was a forward split with a ratio of 1.2983349.

Last Split Date	Jul 11, 2019
Split Type	Forward
Split Ratio	1.2983349

Scores

Tibet Cheezheng Tibetan Medicine has an Altman Z-Score of 4.31.

Altman Z-Score	4.31
Piotroski F-Score	n/a